Tobias Jeffrey K

NeurogesX, Inc.

CMO, EVP Research & Deve

Avg. Two Year Performance

No Purchase Track Record

82% Avg. Sale Return 35% Compound

Holdings: 5.0K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions